• Investing
  • Stock
Round Table Thoughts
  • Economy
  • Editor’s Pick
Home Stock MRNA Stock Gets an Upgrade: When is the Best Time To Buy?
Stock

MRNA Stock Gets an Upgrade: When is the Best Time To Buy?

by January 3, 2024
by January 3, 2024 0 comment
Share
0
FacebookTwitterPinterestWhatsapp

Last year’s vaccine sales decline hurt Moderna’s stock (MRNA), making it one of the worst performers in the S&P 500 in 2023. The weekly chart below will give you a bird’s eye view of how the stock has performed.

Now that the company is widening its offerings to include respiratory syncytial virus (RSV) and influenza vaccines, analysts are noticing MRNA, which received an analyst upgrade. That sent the stock higher in Tuesday’s trading.

CHART 1: WEEKLY CHART OF MRNA STOCK. After being beaten down since its 2021 high, MRNA’s stock price shows signs of rising higher. A break above the 50-week simple moving average could confirm the uptrend.

Chart source: StockCharts.com. For educational purposes.Is now a good time to buy MRNA stock? Let’s look at the daily chart.

CHART 2: DAILY CHART OF MRNA STOCK PRICE. The stock has broken above its upper Bollinger Band, its RSI is above 70, and its SCTR score is shy of 70. If price continues rising and has the momentum for more upside, this stock could be worth buying.Chart source: StockCharts.com. For educational purposes.

The Upside

MRNA’s stock price has broken above its upper Bollinger Band®, and its relative strength index (RSI) is above 70, indicating that it’s in overbought territory. But it has just crossed over the 70 level, which means there could be room for further upside in the stock.

The StockCharts Technical Rank (SCTR) score has spiked up and is just shy of the 70 level. A cross above 70 would make it a strong candidate for an upside move.

Volume is another indicator that can help gauge momentum in a stock. Volume spiked on Tuesday, which is a good indication of upside momentum. If volume remains above average as the stock price moves higher, that indicates positive momentum. As long as the stock continues to show technical strength, MRNA stock could be a good long candidate to add to your portfolio.

One day doesn’t confirm a trend, but it’s worth adding MRNA to your ChartLists. If momentum looks strong and MRNA’s stock price continues to rise and break above its 50-week SMA on the weekly chart, that would be a good time to open a long position in MRNA stock. This year may be a turnaround year for MRNA’s stock price.

The Downside

When investing in stocks, your priority is to protect your positions. So, always anticipate that things could go in the opposite direction.

Watch For Non-Confirmation In the Bollinger Bands

It helps to look for the following three scenarios:

A security creates a reaction high above the upper band. There’s a pullback towards the middle band. Prices move above the prior high but fail to reach the upper band. This is a warning sign. The inability of the second reaction high to reach the upper band shows waning momentum, which can foreshadow a trend reversal. The final confirmation comes with a support break or bearish indicator signal.

The Significance of the SCTR Score

In a nutshell, SCTR is a numerical score that ranges from 1 to 100. The higher the value, the higher the stock’s rank. To get a high SCTR rank, a stock or ETF should score high, with all the indicators used to calculate the SCTR score in the short-, medium-, and long-term time frames.

The SCTR score identifies the leaders and laggards within specific industry groups. Since the calculations are done for you, you only have to add the indicator panel on SharpCharts or StockChartsACP.

The Bottom Line

MRNA’s stock price had the biggest upmove in the S&P 500 on the first trading day of 2024. If MRNA breaks above its 50-week SMA, the next resistance level is around $200, which is much higher than the analyst’s price target. This year could be a turnaround year for MRNA. Biotech stocks can be challenging, since any mishaps in drug production can send the stock price into the doldrums. So, if you are investing in MRNA, watch the charts closely and be prepared to sell the stock on any signs of weakness.

Disclaimer: This blog is for educational purposes only and should not be construed as financial advice. The ideas and strategies should never be used without first assessing your own personal and financial situation, or without consulting a financial professional.

You Might Also Like
  • Smashed Names Showing Life
  • Dow Bounces Off Support: A New High in the Cards?
  • Week Ahead: What Should You Do As Nifty Marches Higher Towards The Resistance Zone?
  • Week Ahead: NIFTY May Stay Vulnerable At Higher Levels; This Sectors Rolls Inside The Leading Quadrant
Share
0
FacebookTwitterPinterestWhatsapp

previous post
Federal appeals court denies Michael Cohen’s attempt to revive lawsuit against Trump
next post
The Science and Art of Stock Market Predictions

You may also like

Bullish Holiday Seasonality Promises More Gains; Three Value Sectors to...

November 20, 2023

Small-Caps Take Pole Position In Overbought Market

December 8, 2023

SCTR Report: China Adds More Stimulus, FXI in Second Position

September 26, 2024

Three Industrial Stocks With Room to Run!

March 27, 2024

Economic Modern Family: More to Prove to Traders

February 13, 2023

With the Fed on Hold, Santa Just Revved Up the...

December 4, 2023

Stock Market Momentum Slows Down: What This Means for Investors

March 25, 2025

MEM TV: How to Trade Nvidia After Its 15% Gain

May 25, 2024

How the Market is Shaping Up After 3 Weeks Down

August 25, 2023

Decisive Long-Term Breakout for Gold

March 15, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Breakouts, Momentum & Moving Averages: 10 Must-See Stock Charts Right Now

      May 31, 2025
    • Leadership Rotation Could Confirm Corrective Phase

      May 30, 2025
    • Run Your Stock Portfolio Like a Pro Sports Team

      May 30, 2025
    • U.S. foreign tax bill sends jitters across Wall Street

      May 30, 2025
    • Amazon taps Xbox co-founder to lead new team developing ‘breakthrough’ consumer products

      May 30, 2025

    Popular Posts

    • 1

      Trump-era China sanctions ended by Biden may be...

      June 27, 2024 2,765 views
    • 2

      Walz’s honeymoon with China gets fresh scrutiny as...

      August 9, 2024 2,472 views
    • 3

      Biden appointee played key role in recruiting Chinese...

      June 25, 2024 2,451 views
    • 4

      Shein’s global ambitions leaves some cybersecurity experts fearful...

      July 10, 2024 2,432 views
    • 5

      Harris VP pick spent years promoting research facility...

      August 29, 2024 2,308 views

    Categories

    • Economy (7,009)
    • Editor's Pick (2,106)
    • Investing (538)
    • Stock (2,581)

    Popular Posts

    • 1

      Trump-era China sanctions ended by Biden may be revived under new House GOP bill

      June 27, 2024
    • 2

      Walz’s honeymoon with China gets fresh scrutiny as Harris camp blasts ‘lying’ critics

      August 9, 2024
    • 3

      Biden appointee played key role in recruiting Chinese businesses to Delaware: ‘Longtime friends’

      June 25, 2024
    • 4

      Shein’s global ambitions leaves some cybersecurity experts fearful of Chinese spy threats

      July 10, 2024
    • 5

      Harris VP pick spent years promoting research facility that collaborated with ‘Chinese military company’

      August 29, 2024

    Latest News

    • Breakouts, Momentum & Moving Averages: 10 Must-See Stock Charts Right...

      May 31, 2025
    • Leadership Rotation Could Confirm Corrective Phase

      May 30, 2025
    • Run Your Stock Portfolio Like a Pro Sports Team

      May 30, 2025

    Categories

    • Economy (7,009)
    • Editor's Pick (2,106)
    • Investing (538)
    • Stock (2,581)

    Disclaimer: RoundTableThoughts.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 RoundTableThoughts.com. All Rights Reserved.

    Round Table Thoughts
    • Investing
    • Stock
    Round Table Thoughts
    • Economy
    • Editor’s Pick

    Read alsox

    Large-Cap Growth Threatens the S&P Rally

    June 25, 2024

    Want More Market Insights and Trade...

    June 10, 2023

    RRG Indicates That non-Mega Cap Technology...

    April 11, 2024
    Sign In

    Keep me signed in until I sign out

    Forgot your password?

    Password Recovery

    A new password will be emailed to you.

    Have received a new password? Login here